Oncolytic herpes simplex viruses type 1 (oHSVs) such as G47D and G207 are genetically engineered for selective replication competence in cancer cells. Several factors can influence the overall effectiveness of oHSV tropism, including HSV-1 receptor expression, extracellular matrix milieu and cellular permissiveness. We have taken advantage of human prostate organ cultures derived from radical prostatectomies to investigate oHSV tropism. In this study, we show that both G47D and G207 specifically replicate in epithelial cells of the prostatic glands but not in the surrounding stroma. In contrast, both the epithelial and stromal cell compartments were readily infected by wild-type HSV-1. Analysis of oHSV replication in prostate surgical specimens 3 days post infection showed that G47D generated B30-fold more viral progeny than did G207. This correlated with the enhanced expression of G47D-derived glycoprotein gB protein levels as compared with G207. In benign prostate tissues, G207 and G47D titers were notably reduced, whereas strain F titers were maintained at similar levels compared with prostate cancer specimens. Overall, our results show that these oncolytic herpes vectors show both target specificity and replication competence in human prostate cancer specimens and point to the utility of using human prostate organ cultures in assessing oHSV tropism and cellular specificity.
Oncolytic herpes simplex viruses type 1 (oHSVs) such as G47D and G207 are genetically engineered for selective replication competence in cancer cells. Several factors can influence the overall effectiveness of oHSV tropism, including HSV-1 receptor expression, extracellular matrix milieu and cellular permissiveness. We have taken advantage of human prostate organ cultures derived from radical prostatectomies to investigate oHSV tropism. In this study, we show that both G47D and G207 specifically replicate in epithelial cells of the prostatic glands but not in the surrounding stroma. In contrast, both the epithelial and stromal cell compartments were readily infected by wild-type HSV-1. Analysis of oHSV replication in prostate surgical specimens 3 days post infection showed that G47D generated B30-fold more viral progeny than did G207. This correlated with the enhanced expression of G47D-derived glycoprotein gB protein levels as compared with G207. In benign prostate tissues, G207 and G47D titers were notably reduced, whereas strain F titers were maintained at similar levels compared with prostate cancer specimens. Overall, our results show that these oncolytic herpes vectors show both target specificity and replication competence in human prostate cancer specimens and point to the utility of using human prostate organ cultures in assessing oHSV tropism and cellular specificity. Oncolytic virotherapy is based on the selective killing of tumor cells while sparing the surrounding normal cells. Selectively replication-competent viral vectors, such as oncolytic herpes simplex viruses type 1 (oHSVs) which are genetically engineered from herpes-simplex virus (HSV) type I, represent an attractive strategy for tumorbased therapies because these viruses can specifically replicate and spread in cancer cells in situ, exhibiting oncolytic activity through direct cytopathic effects while sparing normal cells. G207 is a previously described oHSV that has been used in clinical trials. 1 It contains deletions of both copies of gamma34.5 and a LacZ insertion within the ICP6 gene causing its inactivation.
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G47D is a replication-competent HSV-1 vector derived from G207 that also contains an additional deletion within the nonessential a47 gene. 3 A deletion of a47 places the late US11 gene under the control of the immediate early a47 promoter. As a consequence, US11 expression immediately after infection results in the enhanced growth of G47D by precluding the shutoff of protein synthesis. 4, 5 oHSV vectors have undergone extensive preclinical and clinical testing. Our laboratory has previously shown that G47D is more effective than G207 in several tumor models. 3, 6 Importantly for prostate cancer, oHSV vectors have been shown to be nontoxic to normal prostate and the surrounding nerves after intraprostatic inoculation in mice and in non-human primates. 7, 8 In addition, oHSVs are effective against human prostate cancer irrespective of hormone status or radiosensitivity, 6, 9, 10 a major advantage in its application for advanced forms of the disease, in which hormone and radiation refractory tumor is a common cause of progression. Moreover, preexisting immunity does not preclude the efficacy of oHSV vectors in mice. [11] [12] [13] This is critical for translational purposes, as many humans are seropositive for HSV.
Although the use of oHSV for tumor therapy has shown promise, several issues that have hampered their further development for use in clinics still remain. Some of the factors that may limit the overall effectiveness of oHSV as a cancer therapeutic modality include expression of HSV-1 entry receptors, extracellular matrix barrier and intracellular resistance mechanisms.
14 Strategies developed to assess oHSV tropism in monolayer tissue culture do not recapitulate the three-dimensional tumor physiology of multiple cell types as observed in patient and in-patient specimens.
Both human and murine prostate organ cultures have been used extensively to study a wide variety of biological processes ex vivo. [15] [16] [17] [18] We have taken advantage of a prostate organ culture system derived from radical prostatectomies for cancer and from surgeries removing benign prostatic tissue (BPT) to assess oHSV tropism. The advantages of prostate organ cultures are the following: (1) the use of primary human prostate cancer material (as opposed to passaged prostate cancer cell cultures or animal models); (2) the three-dimensional structure remains intact (in contrast to typical monolayer cultures; (3) tumor foci exist at different stages of tumor progression; and (4) the genetic heterogeneity of cancer cells can be studied within and between patient samples. Therefore, the factors that may affect viral entry and replication including cell-cell interactions and cellmatrix interactions remain preserved in this threedimensional milieu and are amenable to exploration.
Assessment of prostate organ cultures for viability and HSV-1 entry receptor expression
Human prostate specimens derived from radical prostatectomies were assessed for both tissue integrity and viability either immediately after resection or 72 h after incubation ex vivo on a semi-submersed collagen sponge (Ultrafoam, Davol, Cranston, RI, USA). A histological analysis showed that the morphological appearance of prostatic glandular regions as well as the surrounding stroma remained intact over the 72-h incubation period. It is noted that, epithelial cell-cell contacts within these glandular regions appeared to be preserved as well as epithelial cell contacts contiguous with the basement membrane ( Figure 1a) . The cell viability of prostate tissues was also assessed using MTS assays (Promega, Madison, WI, USA). As shown in Figure 1b , MTS enzymatic activity was similar for freshly isolated tissues as compared with those cultured over a 3-day period. Nectin-1 is a major cell-surface receptor for HSV-1 entry, the expression of which correlates with oHSV susceptibility and has been shown to be ubiquitously expressed in multiple tissues, including in the prostate. 19, 20 Therefore, we assessed the tissue distribution of nectin-1 in prostate surgical specimens by immunohistochemistry. Anti-nectin-1 (R166) antibody 21, 22 strongly stained 3 pieces and placed on semi-submersed collagen sponge (Ultrafoam, Davol, Cranston, RI, USA) in prostate organ culture (POC) medium (RPMI-1640 medium containing 10% fetal calf serum, 2 mM non-essential amino acids and antibiotics) for 3 days and subsequently frozen. H&E-stained sections were assessed for tissue integrity. Scale bar ¼ 50 mm.
(b) Assessment of prostate tissue viability. Freshly obtained (D0) or D3-derived organ cultures were cut into small cubes, incubated with MTS for 4 h at 37 1C, the absorbance was read at a wavelength of 490 nm, and protein concentrations were subsequently determined as previously described. 27 (c) Anti-nectin-1 immunostaining in prostate cancer tissue. Prostate tissue specimens from pathology were immediately fixed in 10% formalin overnight and embedded in paraffin. Tissue retrieval was performed by incubation in 10% sodium citrate at 95 1C for 20 min. Serial tissue sections were either stained with normal rabbit immunoglobulin (left panels) (Dakocytomation, Carpinteria, CA, USA) or the anti-Nectin-1 R166 antibody 21 for 1 h at room temperature, followed by anti-rabbit-HRP conjugated secondary antibody for 45 min (middle and right panels). Nectin-1 tissue distribution was subsequently revealed using the DAB-Chromogen system (Dakocytomation). Scale bar ¼ 50 mm. The strong staining of nectin-1 on epithelial cells and the faint staining throughout the stroma (black arrows) is noted. Photographs depict two separate images from different microscopic area of the same prostate cancer specimen. oHSV preferentially targets epithelial cells of the prostatic ducts but not of stromal cells
We initially assessed the target specificity of G47D within prostate surgical specimens by X-gal staining. G47D contains a LacZ insertion in the ICP6 gene, which allows for viral tracking. Organ culture conditions were optimized to detect G47D infectivity while minimizing incubation times to preserve tissue integrity. G47D (1.5 Â 10 6 p.f.u. (plaque forming units)) was placed in a medium with prostate tissue specimens for 1.5 h, and the specimens were subsequently transferred into a semisubmersed collagen-matrix for an additional 2-3 days resulting in the detection of b-gal + cells (Figure 2a) . It is noted that, X-gal staining appeared to be confined to epithelial cells within the prostatic glands with negligible staining detected in the surrounding stroma. Senescenceinduced b-gal expression in prostate tissues has been detected by X-gal staining; 23 however, b-gal expression was not detected in uninfected tissues (data not shown).
Immunostaining of serial sections with anti-HSV gB, which recognizes the cell-surface glycoprotein B, a late gene product of HSV-1, confirmed the replication of G47D within these glandular regions but not in the stroma (Figure 2a) . Staining with the luminal-specific epithelial anti-cytokeratin-8/18 antibody, further showed that both b-gal + and gB + regions likely represented p.f.u.) for 1.5 h in 250 ml of POC medium and thereafter, placed on a semi-submersed collagen sponge in prostate organ culture (POC) medium. Tissue specimens were frozen in O.C.T 2 or 3 days post infection, sectioned (5 mm) and stained for b-galactosidase activity (upper panels) as previously described. 28 Anti-HSV-1 gB (Virusys Corp., Sykesville, MD, USA) (middle panels) or anti-cytokeratin-8/18 (UCD/PR-10.11, Dakocytomation, Carpinteria, CA, USA) (lower panels) staining was also performed on serial sections. Tissue sections were acetone-fixed and rehydrated. After serum and peroxidase blocking (Dakocytomation), sections were incubated with primary antibody for 1 h, followed by a secondary anti-mouse immunoglobulin coupled to HRP (GE Healthcare, Piscataway, NJ, USA). Antibody staining was detected using the DAB-Chromogen system (Dakocytomation). Sections were counterstained with hematoxylin. It is noted that anti-HSV gB and X-gal staining overlap with the cytokeratin-8/18 + staining. Similar results were observed in all 12 prostate specimens examined. Pt.1 refers to patient specimen-1; Gleason Score 3+3 ¼ 6 (Age 50, TNM tumor stage T2). Scale bar ¼ 50 mm. (b) Nuclear p63 expression in prostate organ cultures. Anti-p63 (4A4; Santa Cruz, Santa Cruz, CA, USA) staining was performed on serial sections from the above-infected D2 and D3-organ cultures (Pt.1) or on a D3 organ culture derived from a benign prostatic tissue (BPT). A representative prostatic gland is depicted. The dark brown nuclear stain of anti-p63 and the hematoxylin counterstain (violet) is noted. Arrows denote p63 positive staining. An isotype-matched control mouse antibody (Neg. Co; Dakocytomation) was used to show background staining. Scale bar ¼ 10 mm. PCa denotes prostate cancer.
oHSVs in human prostate cancer organ cultures BJ Passer et al luminal epithelial cells. LacZ+ and gB+ staining were frequently observed toward the center of the tissue section, suggesting viral penetration. The nuclear protein p63 is expressed in normal basal epithelial cells of the prostate. Furthermore, anti-p63 staining is frequently used as a diagnostic aid the expression of which is either decreased or absent in prostate adenocarcinomas but is present in BPT. 24 Staining with anti-p63 on serial sections derived from these organ cultures revealed minimal detection in the prostate cancer specimens, whereas the nuclear expression of p63 staining was indeed observed in an organ culture derived from a BPT specimen used as a control (Figure 2b) .
Next, G47D infectivity was compared with G207 and the nonengineered parental HSV-1 (strain F). Anti-gB and anti-cytokeratin-8/18 staining indicated that G207 infectivity was confined to the epithelium of the prostatic glands similar to that of G47D (Figure 3a) . This was in striking contrast to the pattern of infectivity observed for strain F as previously observed in mice. 7 By day 3 post infection with wild-type strain F, anti-HSV gB-positive staining appeared not only within the epithelial-containing glandular regions but was also prevalent in the stroma as verified by anti-cytokeratin 8/18 immunostaining (Figure 3a) . That is, HSV-1 gB expression was noted in regions that lacked anti-cytokeratin 8/18 staining. Thus, these data show that although G47D and G207 infection appears confined to the epithelia within the prostatic glands, wild-type HSV-1 is more promiscuous in nature, spreading throughout both the epithelia as well as the stroma. In addition, these data also suggest that although G47D has the capacity to infect Prostate cancer tissues were infected as detailed above and 3 days post infection, specimens were fixed, sectioned and stained with either the anti-HSV gB antibody (left panels) or anti-cytokeratin-8/18 antibody (right panels) on serial sections. It is noted that G207 is confined to cytokeratin-8/18 + epithelial cells, whereas strain F is present in both epithelial as well as stromal cells. Sections were counterstained with hematoxylin. Pt.5 was infected with either G47D or wild-type strain F. Scale bar ¼ 50 mm. Pt.2-6 refers to patient specimens 2 through 6 representing Gleason Scores of 3+2 ¼ 5 (Pt.2: age 69 years, TNM tumor stage T2); 3+3 ¼ 6 (Pt.5: age 58 years, TNM tumor stage T2) 3+4 ¼ 7 (Pt.3: age 58 years, TNM stage T2; Pt.4: age 64 years, TNM tumor stage T3; Pt.6: age 66 years, TNM tumor stage T2). (b) Kinetic analysis of G47D and G207-derived gB protein expression. Prostate specimens were inoculated with either G47D or G207 (1 Â 10 6 p.f.u.) for 1.5 h and placed on a collagen matrix for 1 or 3 days. Immunoblot analysis was performed on infected tissue lysates using either anti-gB (Virusys Corp., Sykesville, MD, USA) or anti-cytokeratin-18 antibody (DC-10; Santa Cruz, Santa Cruz, CA, USA). Anti-b-actin was used as a loading control. Approximately 50 mg of protein was loaded per lane (c) Tissue distribution of G47D and strain F in benign prostatic tissue (BPT) samples. Tissues were infected and at 3 days post infection, specimens were fixed, sectioned and stain with anti-HSV gB. It is noted that the majority of anti-gB staining in G47D infected tissues was identified in glandular regions near the rim of the tissue, whereas strain F infectivity resulted in a ubiquitous anti-gB staining to both glandular and non-glandular regions. (d) Quantification of oHSV viral titers in prostate organ cultures. Prostate cancer (left panel) and benign prostatic (right panel) tissue specimens infected with G207, G47D or strain F were maintained on a collagen support for 3 days. Virus titers were determined by titration of tissue homogenates on Vero cells using plaque assays. 3 Tissues weights were determined to correct for viral titer concentrations. (Average±s.e.m; paired Student's t-test). Each color dot indicates a different prostate surgical specimen that was separately infected with one of the three indicated viruses (n ¼ 6). Pt.7-12 refers to patient specimens 7 through 12 representing Gleason Scores of 3+3 ¼ 6 (Pt. oHSVs in human prostate cancer organ cultures BJ Passer et al both epithelial and stroma cells similar to strain F, its genetic alterations restrict its ability to spread in the epithelium. In BPT specimens, G47D infectivity resulted in limited distribution to glands at the periphery of tissue, whereas strain F infectivity was frequently observed in both glandular and non-glandular areas throughout the tissue (Figure 3c ). In parallel, prostate cancer tissue lysates derived from G47D and G207-infected organ cultures were monitored by immunoblot analysis over a 3-day period for HSV-1 gB expression levels, an indicator of viral replication (Figure 3b ). Although gB expression was undetected for either vector by D1 post infection, G47D-expressed gB was clearly visible by D3 and moreover, was substantially more prominent than for G207. Finally, we assessed oHSV replication by quantifying viral progeny in these prostate surgical specimens. Tissue samples (n ¼ 6) were infected as described above with G207, G47D or strain F, and infectious viral titers were subsequently determined 3 days post infection. Figure 3c summarizes ) achieving a 28-fold increase in viral titer. We estimate that on average, the input for each infection was 6 Â 10 4 p.f.u. mg À1 of protein from B25 mg of total tissue weight. The increase in strain F viral titers likely reflects, at least in part, its non-selectivity in its ability to spread and replicate in both epithelial and stromal cell compartments. Finally, oHSV infection of BPT specimens resulted in notably reduced viral titers for both G207, G47D, whereas viral titers for strain F were maintained at comparable levels relative to prostate cancer samples (Figure 3d) .
Collectively, our studies show the suitability of using prostate surgical specimens to assess oHSV tropism. In accordance with previously published studies, prostate tissues can be maintained on a matrix support system. 15, 16 The heterogeneous nature of prostate cancer specimens as well as the presence of Nectin-1, a major HSV-1 entry receptor, makes their use in organ cultures particularly attractive to evaluate oHSV tropism. Although both G47D and G207 were observed to preferentially target cytokeratin-8/18-positive epithelial cells, wild-type HSV-1 was also prevalent throughout the stroma. Moreover, the replication efficacy of G47D was consistently superior to that of G207 in these surgical samples. The molecular basis for these differences in replication is due to the immediate-early expression of Us11 after G47D infection that compensates for the loss of gamma34.5. Us11 protein has been shown to counteract the activities of eIF2a kinase PKR, PACT and 2 0 -5 0 -oligoadenylate synthetase, which are all critical for host defense. 25 Finally, although we did not observe a correlation between tumor grade and viral infectivity more samples may need to be assessed. Thus, the unique genetic modifications built into these oHSVs confer celltype specific replication competence in prostate surgical specimens. When these data are considered in conjunction with the equivalent lack of neurotoxicity of G47D and G207 after direct injection in the brains of HSV susceptible mice, 3, 26 these data suggest that G47D should be considered for further development for prostate cancer therapy. The specificity of this model system should also allow assessment of the efficacy of oHSV virotherapy in combination with chemotherapeutics and appropriate small molecule pharmaceuticals.
